#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13968	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2082	667.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	805	C	713	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13968	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2082	667.3	0	HET	.	.	.	C451T	.	451	451	C	682	682	C	845	C,T	584,178	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13968	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2082	667.3	0	HET	.	.	.	C207T	.	207	207	C	438	438	C	851	C,T	610,132	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26058	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3486	745.6	0	.	n	.	0	T695C	SNP	695	695	T	1009	1009	C	824	C,T	724,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26058	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3486	745.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2285	2285	C	824	C	733	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26058	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3486	745.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2359	2359	A	830	A,C	746,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26058	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3486	745.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2911	2911	C	782	C,A	723,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26058	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3486	745.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1952	1952	A	897	A,G	607,199	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1802	folP	855	855	100.0	folP.l15.c30.ctg.1	1507	119.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1000	1002	AGC	203;202;203	A;G,A;C	182;180,1;180	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3365	131.6	1	SNP	p	S91F	1	.	.	271	273	TTC	575	577	TTC	154;152;153	T;T;C	138;137;138	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3365	131.6	1	SNP	p	G95N	0	.	.	283	285	GGC	587	589	GGC	149;146;145	G;G,C;C	136;133,1;135	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.96	gyrA.l6.c17.ctg.1	3365	131.6	1	SNP	p	D95G	1	.	.	283	285	GGC	587	589	GGC	149;146;145	G;G,C;C	136;133,1;135	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1398	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1327	104.9	1	SNP	p	G45D	0	.	.	133	135	GGC	560	562	GGC	205;202;202	G;G;C	178;178;176	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	708	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	845	83.1	0	.	n	.	0	A197.	DEL	197	197	A	491	491	A	189	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5740	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2924	195.9	1	SNP	p	D86N	0	.	.	256	258	GAC	545	547	GAC	219;215;216	G;A;C	191;187;190	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5740	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2924	195.9	1	SNP	p	R87I	0	.	.	259	261	CGT	548	550	CGT	218;217;219	C;G;T	190;189;191	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5740	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2924	195.9	1	SNP	p	S87R	1	.	.	259	261	CGT	548	550	CGT	218;217;219	C;G;T	190;189;191	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5740	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2924	195.9	1	SNP	p	R87W	0	.	.	259	261	CGT	548	550	CGT	218;217;219	C;G;T	190;189;191	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5740	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2924	195.9	1	SNP	p	S88P	0	.	.	262	264	TCC	551	553	TCC	220;219;220	T;C,A;C	195;193,1;194	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4042	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2493	161.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1489	1491	GGC	181;173;173	G;G;C	163;158;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1161	1163	GCC	213;214;211	G;C;C	190;191;188	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1164	1166	ATG	214;212;213	A;T,A;G	192;190,1;193	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1176	1178	ACC	206;205;204	A;C,G;C	187;187,1;187	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1176	1178	ACC	206;205;204	A;C,G;C	187;187,1;187	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1677	1679	ACC	216;213;216	A;C;C	185;185;188	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1731	1733	GCG	189;186;186	G;C;G	169;169;168	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1731	1733	GCG	189;186;186	G;C;G	169;169;168	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1854	1856	GGT	169;167;168	G;G;T	143;141;141	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1863	1865	AGC	161;162;162	A;G;C	135;140;135	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3570	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2235	158.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1881	1883	CCG	152;153;149	C,G;C,A;G	110,4;114,1;107	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5706	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3071	185.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1611	1613	CCG	210;212;212	C;C;G	181;191;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2146	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1589	134.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	466	466	C	143	C	128	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	A251V	NONSYN	751	753	GCG	82	84	GTA	48;48;48	G;T;A	41;41;41	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	142	144	ACT	75;73;73	A;C;T	58;58;58	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	148	150	GAT	60;59;57	G;A;T	50;49;48	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	D276N	NONSYN	826	828	GAT	157	159	AAC	59;59;58	A;A;C	49;49;49	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	160	162	CAC	57;57;57	C;A;C	48;48;48	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	250	252	GAA	15;15;15	G;A;A	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	262	264	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	265	267	GAC	15;15;15	G;A;C	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	271	273	ATC	15;15;15	A;T;C	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	277	279	TCG	15;15;15	T;C;G	15;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	283	285	GCC	14;14;14	G;C;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	286	288	AGC	14;14;14	A;G;C	14;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	289	291	GCC	13;14;14	G;C;C	13;14;14	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	272	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	374	32.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	295	297	GTT	14;15;14	G;T;T	14;15;14	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1388	202.4	1	SNP	p	G120K	1	.	.	358	360	AAG	593	595	AAG	226;224;225	A;A;G	202;202;201	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1388	202.4	1	SNP	p	A121N	1	.	.	361	363	AAC	596	598	AAC	225;226;227	A;A;C	204;205;204	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1388	202.4	1	SNP	p	N121D	0	.	.	361	363	AAC	596	598	AAC	225;226;227	A;A;C	204;205;204	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10352	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4824	214.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1118	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1008	110.2	1	SNP	p	V57M	1	.	.	169	171	ATG	567	569	ATG	240;241;241	A;T;G	216;219;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
